Microfluidic Microcapsule In Vitro Evolution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current in vitro systems for molecular evolution, such as phage display and SELEX, are limited in their ability to select for diverse biochemical and biological activities, including catalytic and regulatory activities, and cannot evolve both nucleic acids and proteins to achieve a full range of activities like natural systems.

Innovation Solution

A method involving compartmentalization of genetic elements into microcapsules using microfluidic systems to physically link nucleic acids and their encoded gene products, allowing for the selection and sorting of genetic elements based on desired activities through optical changes or direct modification, enabling iterative rounds of mutation and selection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If phage display technology is used to link nucleic acid and encoded protein, then binding activity selection is improved, but the scope of selectable activities is limited to binding only

Engineering Contradiction:
Improvescope of selectable activitiesVSAvoidselection accuracy for catalytic activity
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The system segments the selection process into distinct compartments (microdroplets) where different selection modes can be applied. Each microdroplet contains a single nucleic acid molecule and its encoded product, allowing independent selection for different activities (binding, catalytic, regulatory) without cross-contamination, thus expanding the scope of selectable activities while maintaining selection accuracy

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces an intermediary compartmentalization system using microdroplets as physical mediators between the nucleic acid and selection assay. This intermediary structure enables the same platform to support multiple selection modalities by containing the genotype-phenotype link within isolated compartments, resolving the contradiction between versatility and selection accuracy

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If SELEX method is used for nucleic acid selection, then binding and chemical activity selection are improved, but protein molecules cannot be selected

Engineering Contradiction:
Improverange of selectable moleculesVSAvoidselection reliability for protein activity
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The compartmentalized display system achieves universality by enabling the same microdroplet-based platform to select for multiple molecule types (nucleic acids and proteins) and multiple activity types (binding, catalytic, regulatory). The microdroplet compartment serves as a universal container that maintains the genotype-phenotype link regardless of molecule type, thus expanding the range of selectable molecules while maintaining reliable selection

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

By segmenting the system into individual microdroplet compartments, the invention allows simultaneous selection for different molecule types and activities without cross-interference. Each compartment independently maintains the nucleic acid-protein link, enabling reliable protein activity selection while expanding versatility to include both nucleic acid and protein molecules

Inventive Principle:
Principle #1Segmentation

3Reliability

If compartmentalization into microcapsules is implemented, then linkage between nucleic acid and gene product activity is improved, but device complexity increases

Engineering Contradiction:
Improvelinkage between nucleic acid and gene productVSAvoidmicrofluidic system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention replaces complex mechanical manipulation of individual microcapsules with microfluidic flow-based handling. Microdroplets are generated, manipulated, and sorted using fluid dynamics and electromagnetic fields rather than mechanical manipulation, significantly reducing device complexity while maintaining reliable nucleic acid-gene product linkage through compartmentalization

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system uses microfluidic hydraulic control to generate, manipulate, and sort microdroplet compartments. By employing fluid flow fields and pressure gradients, the system achieves reliable compartmentalization and handling without complex mechanical systems, thus improving nucleic acid-gene product linkage while minimizing device complexity

Inventive Principle:
Principle #29Pneumatics and hydraulics

4Quantity of substance

If large libraries of nucleic acids are created, then diversity of gene products is improved, but selection and isolation of desired molecules becomes more difficult

Engineering Contradiction:
Improvelibrary sizeVSAvoiddifficulty of selection and isolation
Core Design Contradiction:
Quantity of substanceVSDifficulty of detecting and measuring

Solution Approach 1:

The invention segments large nucleic acid libraries into individual microdroplet compartments, with each droplet containing a single nucleic acid molecule. This segmentation enables parallel screening of thousands of individual molecules simultaneously while maintaining simple detection and selection protocols, thus increasing library diversity while reducing the difficulty of selection and isolation

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system uses microfluidic replication to amplify and distribute large numbers of microdroplet compartments containing library members. By creating numerous identical copies of the compartmentalized library in parallel flow streams, the system enables diverse library screening with simplified selection and isolation procedures

Inventive Principle:
Principle #26Copying

Data Source

PatentUS7968287B2In vitro evolution in microfluidic systems
Publication Date: 2011.06.28 UNITED KINGDOM RESEARCH AND INNOVATION
  • US7968287B2 patent drawing
  • US7968287B2 patent drawing
  • US7968287B2 patent drawing

AI summary

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.